The deal marks the second time Novartis has tapped Monte Rosa’s services in just under year. The US big pharma company paid ...

US-based Amneal Pharmaceuticals has secured approval from the FDA for its 500mg/mL sodium oxybate oral solution.

AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, according to reports from ...

FDA chief Martin Makary said the agency will now ‘proactively monitor’ pharma companies for advertising law breaches.

LB Pharmaceuticals’ public listing comes amid a dry spell for biotech IPOs despite a flurry of activity early in 2025.

On this episode, the healthcare editorial team unpicks several key trials and trends from this year’s event, held from 29 ...

AbbVie has struck deals with Rinvoq generic hopefuls as it extends protection for one of its prized assets until 2037.

Kashiv BioSciences has entered a partnership with Brazilian biopharmaceutical company CRISTÁLIA to facilitate the marketing ...

Zentiva, a Czech producer of generic medications, is poised for a change in ownership as Advent has agreed to sell the ...

MSD has scrapped its UK expansion plans due to the government's lack of investment in the life sciences sector.